Research ArticleArticle
Sustained Remission in Tumor Necrosis Factor Inhibitor–treated Patients with Rheumatoid Arthritis: A Population-based Cohort Study
Jon Thorkell Einarsson, Pierre Geborek, Tore Saxne and Meliha C. Kapetanovic
The Journal of Rheumatology February 2015, jrheum.131502; DOI: https://doi.org/10.3899/jrheum.131502
Jon Thorkell Einarsson
From the Department of Clinical Sciences Lund, Section of Rheumatology, Lund University, Skåne University Hospital, Lund, Sweden. J.T. Einarsson, MD; P. Geborek, MD, PhD; T. Saxne, MD, PhD; M.C. Kapetanovic, MD, PhD, Department of Clinical Sciences Lund, Section of Rheumatology, Lund University, Skåne University Hospital. Supported by grants from the Swedish Rheumatism Association, the Swedish Research Council, the Medical Faculty of Lund University, the Alfred Österlund Foundation, the Crafoord Foundation, the Greta and Johan Kock Foundation, King Gustaf V’s 80-Year Foundation, and Lund University Hospital. Address correspondence to Dr. J.T. Einarsson, Department of Clinical Sciences Lund, Section of Rheumatology, Skåne University Hospital, Lund University, Kioskgatan 3, SE-221 85 Lund, Sweden. E-mail: jonthorkell@gmail.com Accepted for publication January 2, 2015.
Pierre Geborek
From the Department of Clinical Sciences Lund, Section of Rheumatology, Lund University, Skåne University Hospital, Lund, Sweden. J.T. Einarsson, MD; P. Geborek, MD, PhD; T. Saxne, MD, PhD; M.C. Kapetanovic, MD, PhD, Department of Clinical Sciences Lund, Section of Rheumatology, Lund University, Skåne University Hospital. Supported by grants from the Swedish Rheumatism Association, the Swedish Research Council, the Medical Faculty of Lund University, the Alfred Österlund Foundation, the Crafoord Foundation, the Greta and Johan Kock Foundation, King Gustaf V’s 80-Year Foundation, and Lund University Hospital. Address correspondence to Dr. J.T. Einarsson, Department of Clinical Sciences Lund, Section of Rheumatology, Skåne University Hospital, Lund University, Kioskgatan 3, SE-221 85 Lund, Sweden. E-mail: jonthorkell@gmail.com Accepted for publication January 2, 2015.
Tore Saxne
From the Department of Clinical Sciences Lund, Section of Rheumatology, Lund University, Skåne University Hospital, Lund, Sweden. J.T. Einarsson, MD; P. Geborek, MD, PhD; T. Saxne, MD, PhD; M.C. Kapetanovic, MD, PhD, Department of Clinical Sciences Lund, Section of Rheumatology, Lund University, Skåne University Hospital. Supported by grants from the Swedish Rheumatism Association, the Swedish Research Council, the Medical Faculty of Lund University, the Alfred Österlund Foundation, the Crafoord Foundation, the Greta and Johan Kock Foundation, King Gustaf V’s 80-Year Foundation, and Lund University Hospital. Address correspondence to Dr. J.T. Einarsson, Department of Clinical Sciences Lund, Section of Rheumatology, Skåne University Hospital, Lund University, Kioskgatan 3, SE-221 85 Lund, Sweden. E-mail: jonthorkell@gmail.com Accepted for publication January 2, 2015.
Meliha C. Kapetanovic
From the Department of Clinical Sciences Lund, Section of Rheumatology, Lund University, Skåne University Hospital, Lund, Sweden. J.T. Einarsson, MD; P. Geborek, MD, PhD; T. Saxne, MD, PhD; M.C. Kapetanovic, MD, PhD, Department of Clinical Sciences Lund, Section of Rheumatology, Lund University, Skåne University Hospital. Supported by grants from the Swedish Rheumatism Association, the Swedish Research Council, the Medical Faculty of Lund University, the Alfred Österlund Foundation, the Crafoord Foundation, the Greta and Johan Kock Foundation, King Gustaf V’s 80-Year Foundation, and Lund University Hospital. Address correspondence to Dr. J.T. Einarsson, Department of Clinical Sciences Lund, Section of Rheumatology, Skåne University Hospital, Lund University, Kioskgatan 3, SE-221 85 Lund, Sweden. E-mail: jonthorkell@gmail.com Accepted for publication January 2, 2015.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Sustained Remission in Tumor Necrosis Factor Inhibitor–treated Patients with Rheumatoid Arthritis: A Population-based Cohort Study
Jon Thorkell Einarsson, Pierre Geborek, Tore Saxne, Meliha C. Kapetanovic
The Journal of Rheumatology Feb 2015, jrheum.131502; DOI: 10.3899/jrheum.131502